Profile for ChemoCentryx Inc. (CCXI)

$ 7.63   0.05 (+0.66%) Volume: 354.54k 4:00 PM EDT 16-Sep-2019
After Hours:  $ 7.63 0.00 (0.00%) Volume: 7.14k 4:29 PM EDT 16-Sep-2019
Business Description:
ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.
Address: 850 Maude Avenue, Mountain View, CA, USA, 94043
Telephone: +1 650 210-2900 Website:
Facsimile: +1 650 210-2910 Email: [email protected]
CEO: Thomas J. Schall
Employees: 76 Market Cap: 444.45m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: Biotechnology, Morningstar US Market Factor Tilt PR USD, Morningstar US Market Factor Tilt TR USD
Industry Classifications
Sector: Healthcare CIK: 1340652
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC: Pharmaceutical Preparations (2834)